Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Raised serum interleukin 15 levels in Kawasaki disease.

Jang GC, Kim HY, Ahn SY, Kim DS.

Ann Rheum Dis. 2003 Mar;62(3):264-6.

2.

Circulating interleukin 17 is increased in the acute stage of Kawasaki disease.

Sohn MH, Noh SY, Chang W, Shin KM, Kim DS.

Scand J Rheumatol. 2003;32(6):364-6.

PMID:
15080268
3.

Increased serum levels of macrophage migration inhibitory factor in patients with Kawasaki disease.

Lee TJ, Chun JK, Yeon SI, Shin JS, Kim DS.

Scand J Rheumatol. 2007 May-Jun;36(3):222-5.

PMID:
17657678
4.

Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.

Ge X, Li CR, Yang J, Wang GB.

Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022.

5.

[Value of serum soluble interleukin-2R, interleukin-6 and C-reactive protein in the early diagnosis of Kawasaki disease].

Peng Q, Wu Q, Chen CH, Hong H, Zhang LY.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Jun;8(3):208-10. Chinese.

PMID:
16787593
6.

Serum levels of interleukin-18 are elevated in the subacute phase of kawasaki syndrome.

Nomura Y, Masuda K, Maeno N, Yoshinaga M, Kawano Y.

Int Arch Allergy Immunol. 2004 Oct;135(2):161-5. Epub 2004 Sep 2.

PMID:
15345916
7.
8.

Kawasaki disease differs from anaphylactoid purpura and measles with regard to tumour necrosis factor-alpha and interleukin 6 in serum.

Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K.

Eur J Pediatr. 1992 Jan;151(1):44-7.

PMID:
1728545
9.

Increased serum levels of vascular endothelial growth factor in Kawasaki disease.

Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, Maruyama I, Miyata K.

Pediatr Res. 1998 Oct;44(4):596-9.

PMID:
9773852
10.

Decrease in the concentrations of transforming growth factor-beta 1 in the sera of patients with Kawasaki disease.

Matsubara T, Umezawa Y, Tsuru S, Motohashi T, Yabuta K, Furukawa S.

Scand J Rheumatol. 1997;26(4):314-7.

PMID:
9310113
11.

Circulating adiponectin levels in Kawasaki disease.

Takeshita S, Takabayashi H, Yoshida N.

Acta Paediatr. 2006 Oct;95(10):1312-4.

PMID:
16982510
12.

Serum levels of p60 soluble tumor necrosis factor receptor during acute Kawasaki disease.

Furukawa S, Matsubara T, Umezawa Y, Okumura K, Yabuta K.

J Pediatr. 1994 May;124(5 Pt 1):721-5.

PMID:
8176558
13.

Increased serum interleukin-10 level in Kawasaki disease.

Kim DS, Lee HK, Noh GW, Lee SI, Lee KY.

Yonsei Med J. 1996 Apr;37(2):125-30.

14.

Elevated circulating tumor necrosis factor-alpha in patients with Kawasaki disease.

Maury CP, Salo E, Pelkonen P.

J Lab Clin Med. 1989 May;113(5):651-4.

PMID:
2715685
15.

Increased levels of circulating intercellular adhesion molecule 1 in Kawasaki disease.

Furukawa S, Imai K, Matsubara T, Yone K, Yachi A, Okumura K, Yabuta K.

Arthritis Rheum. 1992 Jun;35(6):672-7.

PMID:
1350908
16.

Interleukin-18 and coronary artery lesions in patients with Kawasaki disease.

Weng KP, Hsieh KS, Huang SH, Ou SF, Lai TJ, Tang CW, Lin CC, Ho TY, Liou HH, Ger LP.

J Chin Med Assoc. 2013 Aug;76(8):438-45. doi: 10.1016/j.jcma.2013.04.005. Epub 2013 Jun 13.

17.

Plasma Endothelial Microparticles, TNF-a and IL-6 in Kawasaki Disease.

Tan Z, Yuan Y, Chen S, Chen Y, Chen TX.

Indian Pediatr. 2013 May 8;50(5):501-3. Epub 2012 Nov 5.

18.

Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease.

Kuo HC, Yang YL, Chuang JH, Tiao MM, Yu HR, Huang LT, Yang KD, Chang WC, Lee CP, Huang YH.

J Clin Immunol. 2012 Aug;32(4):746-52. doi: 10.1007/s10875-012-9668-1. Epub 2012 Mar 6.

PMID:
22392047
19.

Evaluation of intravenous immunoglobulin resistance and coronary artery lesions in relation to Th1/Th2 cytokine profiles in patients with Kawasaki disease.

Wang Y, Wang W, Gong F, Fu S, Zhang Q, Hu J, Qi Y, Xie C, Zhang Y.

Arthritis Rheum. 2013 Mar;65(3):805-14. doi: 10.1002/art.37815.

20.

Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.

Mitani Y, Sawada H, Hayakawa H, Aoki K, Ohashi H, Matsumura M, Kuroe K, Shimpo H, Nakano M, Komada Y.

Circulation. 2005 Jan 4;111(1):38-43. Epub 2004 Dec 20.

Supplemental Content

Support Center